Abstract
The fusion of 18-fluorodeoxyglucose (FDG) positron-emission tomography (PET) with computed tomography (CT) offers both anatomic and physiologic delineation of head and neck cancers. PET-CT is useful in the staging of head and neck carcinomas and may identify unsuspected distant metastasis that may alter treatment. PET-CT may also help in target volume delineation during radiotherapy (RT) treatment planning. Better characterization of the target may improve local control as well as spare normal tissues from RT sequelae.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 241-246 |
| Number of pages | 6 |
| Journal | ONCOLOGY |
| Volume | 19 |
| Issue number | 2 |
| State | Published - 2005 |
| Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research